思科公司(Cisco Systems)和辉瑞制药公司股价上涨0.6%，领涨道琼斯工业平均指数。
Cisco Systems Inc. and Pfizer Inc. were the biggest gainers in the Dow Jones Industrial Average, rising 0.6 percent each.
辉瑞和其它大制药公司一样都面临着非专利药的威胁，辉瑞公司正进行战略性收缩和重塑。
Like many big pharmas facing a generics threat, Pfizer is slimming down and restructuring.
辉瑞公司上周宣布，已与罗氏和Alnylam一道，就这种形式的RNAi药物运输工具与加拿大生物技术Tekmira制药公司达成一笔交易。
Pfizer last week announced a deal with Canadian biotech Tekmira Pharmaceuticals Corp for this type of delivery vehicle for its RNAi drugs, joining Roche and Alnylam.
在中国开展药物研究的其他主要制药公司包括诺华，阿斯利康，辉瑞，葛兰素史克和罗氏。
Other major drug companies with a research presence in China include Novartis AG, AstraZeneca Plc, Pfizer inc., GlaxoSmithKline and Roche Holding AG.
包括辉瑞和默克在内的美国公司试图在专利到期前几个月推出自己的“授权仿制药”，以减轻仿制药带来的竞争影响。
American firms, including Pfizer and Merck, are trying to launch their own "authorised generics" a few months before patents expire to try to blunt the impact of competition.
但是，包括辉瑞制药在内的外国公司则多次呼吁中国加强对专利、版权和商标的保护。
But foreign companies including Pfizer have repeatedly called on China to tighten patent protections, Copyrights and trademarks.
辉瑞公司创建于1849年，是世界领先的以研发为基础的生物医学和制药公司。
Brightness luck company is founded 1849, it is the world's banner biology medicine that is a foundation with research and development and pharmacy company.
根据此次提供的分别占45%和55%的现金加股票报价，辉瑞制药公司的股东将会持有合并后公司74%的股份，而阿斯利康制药公司的股东将会持有其余股份。
Based on the cash-and-stock offer, 45% and 55% respectively, Pfizer shareholders would hold 74% of the combined company while AstraZeneca shareholders would hold the remaining equity.
辉瑞制药有限公司拥有世界先进的生产设施和检测技术。
PPL is equipped with world advanced manufacturing and testing facilities.
辉瑞制药有限公司拥有世界先进的生产设施和检测技术。
PPL is equipped with world advanced manufacturing and testing facilities.
应用推荐